The Big Picture
State-level momentum and economic data led the headlines on Feb 16, even as U.S. markets were closed for Presidents' Day. Missouri posted a record $1.5 billion in retail cannabis sales for 2025, while several policy moves from Nebraska to Chicago signaled continued political attention to cannabis and hemp regulation.
Why does this matter to you as an investor? Strong retail sales and a defensive turn on local regulation mean companies with operational scale and state licenses could see steadier revenue trajectories, while policy wins reduce near-term regulatory tail risk.
Market Highlights
U.S. equity markets were closed today for Presidents' Day, so market prices are referenced as of Friday, February 13. Use this pause to digest policy shifts and state-level data before trading resumes on Tuesday, February 17.
- Missouri set a 2025 retail record, with $1.5 billion in total sales and $1.3 billion in adult-use sales.
- Cannabis tax revenue in Missouri hit $255 million in 2025, with about $151 million to the state and $104 million to local governments.
- Chicago Mayor Brandon Johnson vetoed a citywide ban on intoxicating hemp product sales, keeping the market open for edibles, flower, and vapes in the city.
- Nebraska congressional candidates pledged to protect medical marijuana access and resist federal intervention, reinforcing pro-reform sentiment ahead of November.
- Regulatory and policy issues to watch include Pennsylvania's legalization revenue forecast of $729 million in year one and New Hampshire's legislative move to legalize therapeutic psilocybin.
- Track these sector names heading into next week: $MSOS, $TCNNF, $GTBIF, $CURLF, $TLRY as barometers of investor appetite for cannabis exposure.
Key Developments
Missouri Sales Shatter Records, Showing Demand Strength
Missouri's regulated cannabis market hit $1.5 billion in retail sales for 2025, including $1.3 billion from adult-use purchases. The market also generated $255 million in tax revenue, with most proceeds flowing to state and local budgets.
Implications are straightforward for investors: the numbers provide a real-world growth signal, and markets that scale sales while delivering tax revenue are more likely to attract capital and new entrants. Could this be a shot in the arm for multi-state operators and retail-focused chains targeting Midwest expansion?
Policy Wins and Political Pledges Reduce Near-Term Regulatory Risk
Chicago's mayor vetoed a ban on intoxicating hemp product sales, reversing a recent local council move that would have restricted edibles, flower, and vapes. The veto preserves a city market that many retailers rely on and reduces uncertainty for hemp-derived product suppliers.
In Nebraska, congressional candidates pledged to defend medical marijuana access and resist federal overreach. Those campaign promises, paired with local and municipal decisions, suggest a more favorable policy environment in some regions as you consider exposure to state-focused operators.
Broader Reform and Public Debate Remain Active
New Hampshire moved a bipartisan bill through the House to legalize regulated therapeutic psilocybin, signaling momentum in adjacent psychedelics policy. Meanwhile, High Times pushed back against a New York Times editorial calling for stricter cannabis measures, highlighting an ongoing public debate on taxes, THC limits, and medical evidence.
These debates matter because they shape the regulatory frameworks that will determine market size, product mix, and compliance costs for operators. Will taxes or stricter rules blunt legalization momentum in large states like Pennsylvania? That's a key risk to monitor.
What to Watch
As trading resumes Tuesday, Feb 17, you'll want to focus on several near-term items that could shift sentiment or valuations.
- State-level revenue and tax proposals, especially Pennsylvania's budget projection of $729 million in first-year cannabis revenue and the risk of high tax rates reducing market displacement of illicit sales.
- Legislative calendars in New Hampshire and other states exploring psychedelics, since therapeutic markets could open new revenue streams for diversified operators.
- Local regulation trends in major metros like Chicago, where the mayor's veto keeps hemp-derived THC product channels open for retailers and CPGs.
- Sector ETF and large-cap names to watch include $MSOS, $TCNNF, $GTBIF, $CURLF, and $TLRY for early signals of investor appetite and flows into cannabis exposure.
- Operational data from state markets, retail sales reports, and tax remittances. Missouri's record is a benchmark you should compare other markets to, when assessing growth potential.
Bottom Line
- State sales and tax data, notably Missouri's $1.5 billion in 2025 retail sales, give the sector a clear demand signal.
- Local and state policy actions, including Chicago's veto and Nebraska pledges, reduce near-term regulatory uncertainty in key markets.
- Watch tax policy in large states, especially Pennsylvania, because high rates could slow legal market growth and favor illicit sellers.
- $MSOS, $TCNNF, $GTBIF, $CURLF, and $TLRY remain useful trackers for sector sentiment and capital flows heading into next week.
- Expect more state-by-state headlines to guide investment decisions, so stay selective and monitor upcoming legislative calendars closely.
FAQ Section
Q: How should I interpret Missouri's $1.5B sales figure? A: It signals strong consumer demand in a large, regulated market and supports the case that scaled state markets can generate reliable retail and tax revenue.
Q: Will Chicago's veto affect national cannabis stocks? A: The veto mainly matters to companies selling hemp-derived THC products and local retailers, but it also reduces regulatory risk in a major metro, which can support broader sentiment for listed operators.
Q: Should I buy cannabis ETFs now? A: That depends on your risk tolerance. Use ETFs like $MSOS to get diversified exposure, but keep an eye on state tax proposals and upcoming legislation that could shift near-term performance.